vancomycin has been researched along with sanguinarine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Kaul, M; Kelley, C; LaVoie, EJ; Parhi, A; Pilch, DS; Zhang, Y | 1 |
Kaul, M; Kelley, C; Lavoie, EJ; Lu, S; Parhi, A; Pilch, DS | 1 |
Giurleo, D; Kaul, M; LaVoie, EJ; Parhi, A; Pilch, DS; Zhang, Y | 1 |
Chen, W; Ma, S; Song, D; Zhang, N; Zhang, P; Zhang, S | 1 |
Choi, JG; Han, SH; Kang, OH; Keum, JH; Kim, SB; Kim, YG; Kwon, DY; Lee, JH; Mun, SH; Obiang-Obounou, BW; Park, CB; Shin, DW | 1 |
Hamoud, R; Reichling, J; Wink, M | 1 |
6 other study(ies) available for vancomycin and sanguinarine
Article | Year |
---|---|
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Enterococcus faecalis; HEK293 Cells; Humans; Isoquinolines; Molecular Targeted Therapy; Staphylococcus aureus | 2012 |
Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus faecalis; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Staphylococcus aureus; Structure-Activity Relationship | 2013 |
Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Enterococcus faecalis; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Polymerization; Staphylococcus aureus | 2013 |
Modification of 5-methylphenanthridium from benzothiazoles to indoles as potent FtsZ inhibitors: Broadening the antibacterial spectrum toward vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzothiazoles; Cytoskeletal Proteins; Humans; Indoles; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Benzophenanthridines; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Isoquinolines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Species Specificity; Vancomycin | 2011 |
Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria.
Topics: Anti-Bacterial Agents; Benzophenanthridines; Drug Resistance, Multiple, Bacterial; Drug Synergism; Edetic Acid; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoquinolines; Microbial Sensitivity Tests; Vancomycin | 2014 |